XML 96 R76.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock options, restricted stock and performance stock options - Stock Options (Details)
12 Months Ended 18 Months Ended
Jan. 01, 2017
shares
Jan. 01, 2016
shares
Dec. 31, 2016
$ / shares
shares
Dec. 31, 2015
$ / shares
Dec. 31, 2014
$ / shares
Dec. 31, 2016
shares
Jul. 31, 2015
shares
Nov. 30, 2009
shares
Employee stock options | Performance based                
Stock options, restricted stock and performance stock options                
Vesting period     3 years          
Stock options                
Stock options, restricted stock and performance stock options                
Vesting period     4 years          
Weighted average key assumptions used in determining the fair value of options granted                
Estimated dividend yield (as a percent)     0.00% 0.00% 0.00%      
Expected stock price volatility (as a percent)     60.00% 60.00% 60.00%      
Expected life of option in years     6 years 1 month 24 days 5 years 5 years      
Weighted-average option fair value at grant (in dollars per share) | $ / shares     $ 5.800 $ 9.723 $ 2.884      
Stock options | Weighted average                
Weighted average key assumptions used in determining the fair value of options granted                
Weighted-average risk-free interest rate (as a percent)     1.18% 1.60% 1.77%      
Neos Therapeutics, Inc. 2009 Equity Plan                
Stock options, restricted stock and performance stock options                
Shares reserved for issuance under the plan               1,375,037
Neos Therapeutics, Inc. 2009 Equity Plan | Stock options                
Stock options, restricted stock and performance stock options                
Expiration period     10 years          
Expiration period of unexercised vested award after termination of employment     90 days          
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan                
Stock options, restricted stock and performance stock options                
Shares reserved for issuance under the plan             767,330  
Increase in number of shares reserved and available for issuance   800,797            
Increase to the number of shares reserved and available for issuance as a percentage of outstanding common stock (as a percent)   5.00%            
Stock option exercise price, minimum expressed as percentage of fair market value on grant date     100          
Shares related to forfeited prior plan options transferred into shares available under current plan           7,500    
Share of restricted stock transferred into shares available under current plan           18,906    
Shares available for grant     210,599     210,599    
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan | Subsequent event                
Stock options, restricted stock and performance stock options                
Shares reserved for issuance under the plan 1,013,648              
Increase in number of shares reserved and available for issuance 803,049              
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan | Stock options                
Stock options, restricted stock and performance stock options                
Expiration period     10 years          
Expiration period of unexercised vested award after termination of employment     90 days